A functional assay to study the pathogenicity of CHD7 protein variants encountered in CHARGE syndrome patients
- 9 July 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 27 (11) , 1683-1691
Abstract
CHARGE syndrome is a rare genetic disease characterized by numerous congenital abnormalities, mainly caused by de novo alterations of the CHD7 gene. It encodes a chromodomain protein, involved in the ATP-dependent remodeling of chromatin. The vast majority of CHD7 alterations consists in null alleles like deletions, nonsense substitutions or frameshift-causing variations. The aim of this study was to develop a biological test of CHD7 protein, to study the impact upon protein functionality of rare allelic variants in the CHD7 gene that elicits changes in the amino acid sequence. Using an expression vector encoding CHD7, three amino acid substitutions and one five-amino acid insertion were generated via site-directed mutagenesis. Then CHD7 proteins, either wild-type (WT) or variants, were overexpressed in HeLa cell line. Protein expression was highlighted by western blot and immunofluorescence. We then used real-time RT-PCR to study CHD7 functionality by evaluating the transcript amounts of five genes whose expression is regulated by CHD7 according to the literature. These reporter genes are 45S rDNA, SOX4, SOX10, ID2, and MYRF. We observed that, upon WT-CHD7 expression, the reporter gene transcriptions were downregulated, whereas the four variant alleles of CHD7 had no impact. This suggests that these alleles are not polymorphisms because the variant proteins appeared nonfunctional. Therefore, these variations can be considered as disease-causing of CHARGE syndrome.Keywords
This publication has 26 references indexed in Scilit:
- Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disordersProceedings of the National Academy of Sciences, 2012
- Identification of CHD7S as a novel splicing variant of CHD7 with functions similar and antagonistic to those of the full‐length CHD7LGenes to Cells, 2012
- CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesisHuman Molecular Genetics, 2010
- Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patternsGenome Research, 2009
- CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndromeClinical Genetics, 2008
- An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocolBMC Biotechnology, 2008
- Mutations in CHD7 in patients with CHARGE syndrome cause T–B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndromeClinical and Experimental Immunology, 2008
- Syntaxin 8 impairs trafficking of cystic fibrosis transmembrane conductance regulator (CFTR) and inhibits its channel activityJournal of Cell Science, 2004
- Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE associationThe Journal of Pediatrics, 1981
- Choanal atresia and associated multiple anomaliesThe Journal of Pediatrics, 1979